Max Hodak: The first people to live to a thousand years may already be alive, brain-computer interfaces will revolutionize healthcare, and ethical considerations are crucial for BCI deployment

Brain-computer interfaces could soon restore vision for the blind, revolutionizing human interaction with technology.

Key takeaways

• Longevity research suggests that the first individuals to live for a thousand years may already be alive today.
• Brain-computer interfaces (BCIs) are expected to diversify, with multiple companies targeting different applications.
• BCI technology developed by Science can help blind patients regain sight by bypassing damaged retinal cells.
• BCIs will evolve similarly to pharmaceuticals, with various modalities tailored for different conditions.
• The risk-reward balance in deploying BCIs should prioritize the most disabled patients.
• The brain remains more plastic throughout life than commonly believed, allowing for learning and adaptation even in adulthood.
• Missing critical periods in early development can lead to irreversible neural issues.
• The brain’s plasticity allows it to adapt and learn from feedback, but this adaptability decreases over time.
• Blind patients often experience hallucinations due to the brain’s attempt to generate visual input without signals from the optic nerve.
• Vision restoration technology could achieve close to native acuity within the next ten years.
• BCIs are poised to revolutionize how we interact with technology and enhance human capabilities.
• Ethical considerations are crucial in the development and deployment of BCIs.
• Neuroplasticity plays a significant role in the potential success of brain-computer interfaces.
• Advancements in biotechnology are driving predictions about extended human longevity.
• The diversity of approaches in the BCI market highlights the technology’s potential impact across various applications.

Guest intro

Max Hodak is the founder and CEO of Science Corporation, a clinical-stage company developing brain-computer interfaces including a retinal implant to restore vision in blind patients. He is a co-founder and former president of Neuralink. Science has treated over 40 patients in clinical trials, with 80% showing improved visual acuity to read letters, numbers, and words.

The future of human longevity

• — Max Hodak

• This prediction is based on current advancements in biotechnology and longevity research.
• The statement reflects a bold vision for the future of human life expectancy.
• Longevity research is rapidly evolving, with potential implications for healthcare and society.
• Understanding the science behind aging is crucial for extending human lifespan.
• Biotechnological advancements are key to unlocking the secrets of longevity.
• The possibility of living to a thousand years challenges current perceptions of aging.
• Ethical and societal considerations will play a significant role in the pursuit of extended longevity.

The evolving landscape of brain-computer interfaces

• — Max Hodak

• BCIs are not a single product but a category with diverse applications.
• Different types of probes will be developed for specific BCI applications.
• The BCI market is expected to see significant growth and diversification.
• BCIs have the potential to revolutionize various industries, including healthcare.
• Understanding the BCI landscape is crucial for identifying future opportunities.
• Collaboration among companies will drive innovation in the BCI field.
• BCIs represent a convergence of technology and neuroscience.

Restoring sight with BCI technology

• — Max Hodak

• The technology uses a tiny array of solar panels to bypass dead rods and cones.
• This innovation provides a visual signal back into the retina, restoring sight.
• Over 40 patients have already benefited from this groundbreaking retinal implant.
• The technology showcases the potential impact of BCIs on vision restoration.
• Understanding retinal diseases is crucial for advancing this technology.
• The success of this technology highlights the promise of BCIs in healthcare.
• BCIs are poised to transform the lives of visually impaired individuals.

BCIs as a new category in medicine

• — Max Hodak

• BCIs will be categorized like pharmaceuticals, with specific applications for different conditions.
• The development of BCIs will require collaboration across multiple disciplines.
• Tailored BCI solutions will address specific medical needs and conditions.
• The potential applications of BCIs in medicine are vast and varied.
• Understanding the medical landscape is crucial for successful BCI deployment.
• BCIs represent a new frontier in personalized medicine.
• Ethical considerations will guide the development of BCIs in healthcare.

Ethical considerations in BCI deployment

• — Max Hodak

• Prioritizing the most disabled patients ensures ethical deployment of BCIs.
• The risk-reward balance is crucial for responsible innovation in BCIs.
• Ethical frameworks will guide the development and deployment of BCIs.
• Understanding the ethical implications is essential for BCI advancement.
• BCIs have the potential to significantly improve the quality of life for disabled individuals.
• Collaboration with ethicists will be crucial for navigating ethical challenges in BCI development.
• Prioritizing patient needs will drive ethical innovation in BCIs.

Neuroplasticity and its implications for BCIs

• — Max Hodak

• Neuroplasticity plays a significant role in the potential success of BCIs.
• Understanding neuroplasticity is crucial for advancing BCI technology.
• The brain’s ability to adapt and learn is key to successful BCI integration.
• Neuroplasticity challenges traditional perceptions of brain function and learning.
• BCIs can leverage neuroplasticity to enhance human capabilities.
• The adaptability of the brain offers new opportunities for BCI innovation.
• Understanding the science of neuroplasticity is essential for BCI development.

Critical periods in neural development

• — Max Hodak

• Early neural development is crucial for optimal brain function.
• Missing critical periods can result in long-term neural challenges.
• Understanding developmental neuroscience is essential for BCI advancement.
• The importance of early neural development highlights the potential of BCIs.
• BCIs can potentially address challenges resulting from missed critical periods.
• Collaboration with developmental neuroscientists will drive BCI innovation.
• Understanding the limitations of neurotechnology is crucial for responsible BCI development.

The brain’s plasticity and learning

• — Max Hodak

• The brain’s plasticity is a key factor in learning and adaptation.
• Understanding brain plasticity is crucial for advancing BCI technology.
• The adaptability of the brain offers new opportunities for BCI innovation.
• BCIs can leverage the brain’s plasticity to enhance human capabilities.
• Understanding the science of brain plasticity is essential for BCI development.
• The brain’s ability to adapt and learn is key to successful BCI integration.
• Neuroplasticity challenges traditional perceptions of brain function and learning.

Sensory perception in blind patients

• — Max Hodak

• Understanding sensory perception is crucial for advancing vision restoration technologies.
• The brain’s attempt to generate visual input highlights its adaptability.
• BCIs can potentially address sensory perception challenges in blind patients.
• Understanding the relationship between sensory input and brain perception is essential for BCI development.
• The adaptability of the brain offers new opportunities for BCI innovation.
• Collaboration with neuroscientists will drive advancements in vision restoration technologies.
• Understanding the complexities of sensory perception is crucial for BCI success.

Vision restoration technology advancements

• — Max Hodak

• Advancements in BCI technology are driving predictions for improved vision restoration.
• The potential for achieving native acuity highlights the promise of BCIs in healthcare.
• Understanding current limitations is crucial for advancing vision restoration technologies.
• Collaboration with experts will drive innovation in vision restoration technology.
• The success of vision restoration technologies showcases the potential impact of BCIs.
• Understanding the science behind vision restoration is essential for BCI development.
• BCIs are poised to transform the lives of visually impaired individuals.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.

Brain-computer interfaces could soon restore vision for the blind, revolutionizing human interaction with technology.

Key takeaways

• Longevity research suggests that the first individuals to live for a thousand years may already be alive today.
• Brain-computer interfaces (BCIs) are expected to diversify, with multiple companies targeting different applications.
• BCI technology developed by Science can help blind patients regain sight by bypassing damaged retinal cells.
• BCIs will evolve similarly to pharmaceuticals, with various modalities tailored for different conditions.
• The risk-reward balance in deploying BCIs should prioritize the most disabled patients.
• The brain remains more plastic throughout life than commonly believed, allowing for learning and adaptation even in adulthood.
• Missing critical periods in early development can lead to irreversible neural issues.
• The brain’s plasticity allows it to adapt and learn from feedback, but this adaptability decreases over time.
• Blind patients often experience hallucinations due to the brain’s attempt to generate visual input without signals from the optic nerve.
• Vision restoration technology could achieve close to native acuity within the next ten years.
• BCIs are poised to revolutionize how we interact with technology and enhance human capabilities.
• Ethical considerations are crucial in the development and deployment of BCIs.
• Neuroplasticity plays a significant role in the potential success of brain-computer interfaces.
• Advancements in biotechnology are driving predictions about extended human longevity.
• The diversity of approaches in the BCI market highlights the technology’s potential impact across various applications.

Guest intro

Max Hodak is the founder and CEO of Science Corporation, a clinical-stage company developing brain-computer interfaces including a retinal implant to restore vision in blind patients. He is a co-founder and former president of Neuralink. Science has treated over 40 patients in clinical trials, with 80% showing improved visual acuity to read letters, numbers, and words.

The future of human longevity

• — Max Hodak

• This prediction is based on current advancements in biotechnology and longevity research.
• The statement reflects a bold vision for the future of human life expectancy.
• Longevity research is rapidly evolving, with potential implications for healthcare and society.
• Understanding the science behind aging is crucial for extending human lifespan.
• Biotechnological advancements are key to unlocking the secrets of longevity.
• The possibility of living to a thousand years challenges current perceptions of aging.
• Ethical and societal considerations will play a significant role in the pursuit of extended longevity.

The evolving landscape of brain-computer interfaces

• — Max Hodak

• BCIs are not a single product but a category with diverse applications.
• Different types of probes will be developed for specific BCI applications.
• The BCI market is expected to see significant growth and diversification.
• BCIs have the potential to revolutionize various industries, including healthcare.
• Understanding the BCI landscape is crucial for identifying future opportunities.
• Collaboration among companies will drive innovation in the BCI field.
• BCIs represent a convergence of technology and neuroscience.

Restoring sight with BCI technology

• — Max Hodak

• The technology uses a tiny array of solar panels to bypass dead rods and cones.
• This innovation provides a visual signal back into the retina, restoring sight.
• Over 40 patients have already benefited from this groundbreaking retinal implant.
• The technology showcases the potential impact of BCIs on vision restoration.
• Understanding retinal diseases is crucial for advancing this technology.
• The success of this technology highlights the promise of BCIs in healthcare.
• BCIs are poised to transform the lives of visually impaired individuals.

BCIs as a new category in medicine

• — Max Hodak

• BCIs will be categorized like pharmaceuticals, with specific applications for different conditions.
• The development of BCIs will require collaboration across multiple disciplines.
• Tailored BCI solutions will address specific medical needs and conditions.
• The potential applications of BCIs in medicine are vast and varied.
• Understanding the medical landscape is crucial for successful BCI deployment.
• BCIs represent a new frontier in personalized medicine.
• Ethical considerations will guide the development of BCIs in healthcare.

Ethical considerations in BCI deployment

• — Max Hodak

• Prioritizing the most disabled patients ensures ethical deployment of BCIs.
• The risk-reward balance is crucial for responsible innovation in BCIs.
• Ethical frameworks will guide the development and deployment of BCIs.
• Understanding the ethical implications is essential for BCI advancement.
• BCIs have the potential to significantly improve the quality of life for disabled individuals.
• Collaboration with ethicists will be crucial for navigating ethical challenges in BCI development.
• Prioritizing patient needs will drive ethical innovation in BCIs.

Neuroplasticity and its implications for BCIs

• — Max Hodak

• Neuroplasticity plays a significant role in the potential success of BCIs.
• Understanding neuroplasticity is crucial for advancing BCI technology.
• The brain’s ability to adapt and learn is key to successful BCI integration.
• Neuroplasticity challenges traditional perceptions of brain function and learning.
• BCIs can leverage neuroplasticity to enhance human capabilities.
• The adaptability of the brain offers new opportunities for BCI innovation.
• Understanding the science of neuroplasticity is essential for BCI development.

Critical periods in neural development

• — Max Hodak

• Early neural development is crucial for optimal brain function.
• Missing critical periods can result in long-term neural challenges.
• Understanding developmental neuroscience is essential for BCI advancement.
• The importance of early neural development highlights the potential of BCIs.
• BCIs can potentially address challenges resulting from missed critical periods.
• Collaboration with developmental neuroscientists will drive BCI innovation.
• Understanding the limitations of neurotechnology is crucial for responsible BCI development.

The brain’s plasticity and learning

• — Max Hodak

• The brain’s plasticity is a key factor in learning and adaptation.
• Understanding brain plasticity is crucial for advancing BCI technology.
• The adaptability of the brain offers new opportunities for BCI innovation.
• BCIs can leverage the brain’s plasticity to enhance human capabilities.
• Understanding the science of brain plasticity is essential for BCI development.
• The brain’s ability to adapt and learn is key to successful BCI integration.
• Neuroplasticity challenges traditional perceptions of brain function and learning.

Sensory perception in blind patients

• — Max Hodak

• Understanding sensory perception is crucial for advancing vision restoration technologies.
• The brain’s attempt to generate visual input highlights its adaptability.
• BCIs can potentially address sensory perception challenges in blind patients.
• Understanding the relationship between sensory input and brain perception is essential for BCI development.
• The adaptability of the brain offers new opportunities for BCI innovation.
• Collaboration with neuroscientists will drive advancements in vision restoration technologies.
• Understanding the complexities of sensory perception is crucial for BCI success.

Vision restoration technology advancements

• — Max Hodak

• Advancements in BCI technology are driving predictions for improved vision restoration.
• The potential for achieving native acuity highlights the promise of BCIs in healthcare.
• Understanding current limitations is crucial for advancing vision restoration technologies.
• Collaboration with experts will drive innovation in vision restoration technology.
• The success of vision restoration technologies showcases the potential impact of BCIs.
• Understanding the science behind vision restoration is essential for BCI development.
• BCIs are poised to transform the lives of visually impaired individuals.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.

Loading more articles…

You’ve reached the end

Add us on Google

`;
}

function createMobileArticle(article) {
const displayDate = getDisplayDate(article);
const editorSlug = article.editor ? article.editor.toLowerCase().replace(/\s+/g, ‘-‘) : ”;
const captionHtml = article.imageCaption ? `

${article.imageCaption}

` : ”;
const authorHtml = article.isPressRelease ? ” : `
`;

return `

${captionHtml}

${article.subheadline ? `

${article.subheadline}

` : ”}

${createSocialShare()}

${authorHtml}
${displayDate}

${article.content}

${article.isPressRelease ? ” : article.isSponsored ? `

Disclosure: This is sponsored content. It does not represent Crypto Briefing’s editorial views. For more information, see our Editorial Policy.

` : `

Disclosure: This article was edited by ${article.editor}. For more information on how we create and review content, see our Editorial Policy.

`}

`;
}

function createDesktopArticle(article, sidebarAdHtml) {
const editorSlug = article.editor ? article.editor.toLowerCase().replace(/\s+/g, ‘-‘) : ”;
const displayDate = getDisplayDate(article);
const captionHtml = article.imageCaption ? `

${article.imageCaption}

` : ”;
const categoriesHtml = article.categories.map((cat, i) => {
const separator = i < article.categories.length – 1 ? ‘|‘ : ”;
return `${cat}${separator}`;
}).join(”);
const desktopAuthorHtml = article.isPressRelease ? ” : `
`;

return `

${categoriesHtml}

${article.subheadline ? `

${article.subheadline}

` : ”}

${desktopAuthorHtml}
${displayDate}
${createSocialShare()}

${captionHtml}

${article.content}
${article.isPressRelease ? ” : article.isSponsored ? `

Disclosure: This is sponsored content. It does not represent Crypto Briefing’s editorial views. For more information, see our Editorial Policy.

` : `

Disclosure: This article was edited by ${article.editor}. For more information on how we create and review content, see our Editorial Policy.

`}

`;
}

function loadMoreArticles() {
if (isLoading || !hasMore) return;

isLoading = true;
loadingText.classList.remove(‘hidden’);

// Build form data for AJAX request
const formData = new FormData();
formData.append(‘action’, ‘cb_lovable_load_more’);
formData.append(‘current_post_id’, lastLoadedPostId);
formData.append(‘primary_cat_id’, primaryCatId);
formData.append(‘before_date’, lastLoadedDate);
formData.append(‘loaded_ids’, loadedPostIds.join(‘,’));

fetch(ajaxUrl, {
method: ‘POST’,
body: formData
})
.then(response => response.json())
.then(data => {
isLoading = false;
loadingText.classList.add(‘hidden’);

if (data.success && data.has_more && data.article) {
const article = data.article;
const sidebarAdHtml = data.sidebar_ad_html || ”;

// Check for duplicates
if (loadedPostIds.includes(article.id)) {
console.log(‘Duplicate article detected, skipping:’, article.id);
// Update pagination vars and try again
lastLoadedDate = article.publishDate;
loadMoreArticles();
return;
}

// Add to mobile container
mobileContainer.insertAdjacentHTML(‘beforeend’, createMobileArticle(article));

// Add to desktop container with fresh ad HTML
desktopContainer.insertAdjacentHTML(‘beforeend’, createDesktopArticle(article, sidebarAdHtml));

// Update tracking variables
loadedPostIds.push(article.id);
lastLoadedPostId = article.id;
lastLoadedDate = article.publishDate;

// Execute any inline scripts in the new content (for ads)
const newArticle = desktopContainer.querySelector(`article[data-article-id=”${article.id}”]`);
if (newArticle) {
const scripts = newArticle.querySelectorAll(‘script’);
scripts.forEach(script => {
const newScript = document.createElement(‘script’);
if (script.src) {
newScript.src = script.src;
} else {
newScript.textContent = script.textContent;
}
document.body.appendChild(newScript);
});
}

// Trigger Ad Inserter if available
if (typeof ai_check_and_insert_block === ‘function’) {
ai_check_and_insert_block();
}

// Trigger Google Publisher Tag refresh if available
if (typeof googletag !== ‘undefined’ && googletag.pubads) {
googletag.cmd.push(function() {
googletag.pubads().refresh();
});
}

} else if (data.success && !data.has_more) {
hasMore = false;
endText.classList.remove(‘hidden’);
} else if (!data.success) {
console.error(‘AJAX error:’, data.error);
hasMore = false;
endText.textContent=”Error loading more articles”;
endText.classList.remove(‘hidden’);
}
})
.catch(error => {
console.error(‘Fetch error:’, error);
isLoading = false;
loadingText.classList.add(‘hidden’);
hasMore = false;
endText.textContent=”Error loading more articles”;
endText.classList.remove(‘hidden’);
});
}

// Set up IntersectionObserver
const observer = new IntersectionObserver(function(entries) {
if (entries[0].isIntersecting) {
loadMoreArticles();
}
}, { threshold: 0.1 });

observer.observe(loadingTrigger);
})();

© Decentral Media and Crypto Briefing® 2026.

Source: https://cryptobriefing.com/max-hodak-the-first-people-to-live-to-a-thousand-years-may-already-be-alive-brain-computer-interfaces-will-revolutionize-healthcare-and-ethical-considerations-are-crucial-for-bci-deployment-y-com/